Order Article Reprints

Kang S, Kim Y, Ahn JY, Jung H-Y, Kim N, Na HK, Lee JH, Jung KW, Kim DH, Choi KD, et al. Role of Antimicrobial Susceptibility Testing before First-Line Treatment Containing Clarithromycin for Helicobacter pylori Eradication in the Clinical Setting. Antibiotics. 2021; 10(2):214. https://doi.org/10.3390/antibiotics10020214

Kang, Seokin, Yuri Kim, Ji Yong Ahn, Hwoon-Yong Jung, Nayoung Kim, Hee Kyong Na, Jeong Hoon Lee, Kee Wook Jung, Do Hoon Kim, Kee Don Choi, and et al. 2021. "Role of Antimicrobial Susceptibility Testing before First-Line Treatment Containing Clarithromycin for Helicobacter pylori Eradication in the Clinical Setting" Antibiotics 10, no. 2: 214. https://doi.org/10.3390/antibiotics10020214

Kang, S., Kim, Y., Ahn, J. Y., Jung, H.-Y., Kim, N., Na, H. K., Lee, J. H., Jung, K. W., Kim, D. H., Choi, K. D., Song, H. J., & Lee, G. H. (2021). Role of Antimicrobial Susceptibility Testing before First-Line Treatment Containing Clarithromycin for Helicobacter pylori Eradication in the Clinical Setting. Antibiotics, 10(2), 214. https://doi.org/10.3390/antibiotics10020214